Recent work suggested that the mutant TP53-driven TNBC subtype, like high grade ovarian cancer, is highly dependent on proteasome function [35] and RA375 showed significant potency against a small panel of TNBC lines. This evidence concerns the gene TP53 and ovarian cancer.